Caribou Biosciences Debt-to-Equity Ratio Growth & History (CRBU)

Caribou Biosciences's debt-to-equity ratio was 0.22 for fiscal 2025.

View full Caribou Biosciences company overview

Caribou Biosciences annual debt-to-equity ratio history

Caribou Biosciences annual debt-to-equity ratio

Fiscal yearPeriod endedDebt-to-equity ratioChangeGrowth
20252025-12-310.220.12+112.82%
20242024-12-310.100.03+42.30%
20232023-12-310.07−0.02−20.21%
20222022-12-310.090.09
20212021-12-310.00

Caribou Biosciences debt-to-equity ratio trends

Between the periods ended 2021-12-31 and 2025-12-31, Caribou Biosciences's debt-to-equity ratio increased from 0.00 to 0.22, a change of 0.22. The latest reported quarter, Q2 2026, shows 0.27.

About the metric

What the debt-to-equity ratio means

The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.

Calculation and source

How debt-to-equity is calculated

TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Caribou Biosciences source filings ↗

Community posts

It’s quiet here.

No posts about CRBU yet. Start the conversation.

Write the first post